| |
|
|
|
Immunogen Inc  
|
|
3.98 0.01 (0%) |
08-05 11:56 |
|
Open: |
3.96 |
Pre close: |
3.97 |
Target:
|
5.35
|
|
High: |
4.075 |
Low: |
3.94 |
Resistance:
|
4.58
4.98
|
|
Volume: |
706,482 |
Market Cap: |
694M |
Support:
|
3.93
3.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.13
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
4.35 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
4.14  |
Stochastic Oscillator |
%K(14,3):
|
15.13 |
|
MA(250): |
3.88 |
%D(3): |
20.57 |
|
Average Volume(K) |
3-Month: |
230723
|
52-Week |
High:
|
7.07 |
|
10-Days: |
186441 |
Low: |
1.95 |
|
RSI |
RSI(14):
|
41.91 |
Change(%): |
42.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.584 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
174.41 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
-10.6 |
Shares Float (M) |
145.36 |
|
EPS Est. Next Year |
-1.380 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.11 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
54.8 |
% Held by Institutions |
76.61 |
|
Forward EPS |
-0.700 |
Gross Profit (p.s.) |
-0.185 |
Shares Short (K) |
16480 |
|
Book Value (p.s.) |
-0.020 |
EBITDA (p.s.) |
-0.283 |
P/E |
-6.93 |
|
Sales Per Share |
0.499 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-202.25 |
|
Profit Margin |
-102.87 |
Operating Cash Flow
(M) |
-126.89 |
P/S |
8.11 |
|
Operating Margin |
-60.52 |
Levered Free Cash Flow
(M) |
-10.47 |
P/CF |
-5.56 |
|
|
|
|
|
|
